Researchers have identified a new method of activating specific molecules to target cancer cells while leaving healthy cells unharmed. Using click-release proteolysis targeting chimeras, researchers have developed a new method of activating specific molecules to target only cancer cells.

The gel releases a steady dose of the anti-HIV drug lamivudine over six weeks, suggesting people living with HIV could have new therapy that doesn't require a daily pill regimen to prevent AIDS.

Boosting virtual screening with machine learning allowed for a 10-fold time reduction in the processing of 1.56 billion drug-like molecules. Researchers teamed up with industry and supercomputers to carry out one of the world's largest virtual drug screens.

A novel drug target has been newly identified in the fight against drug resistance in cancer patients.

An innovative phase 2 clinical trial designed to find new potential treatments for glioblastoma has reported initial results. While none of the three therapeutics tested so far improved overall survival of patients, this adaptive platform trial, the first of its kind in neuro-oncology, has the […]

It's a skin disorder that makes life miserable for around 800 million teenagers and adults worldwide, but cientists may have found an effective treatment for acne, delivered via tiny nanoparticles.